首页> 外国专利> Combating pests with a combination of insecticides and transgenic plants by means of leaf and drench application

Combating pests with a combination of insecticides and transgenic plants by means of leaf and drench application

机译:通过叶和淋的应用与杀虫剂和转基因植物的组合防治害虫

摘要

Transgenic plant production potential utilization involves utilizing a plant with an effective quantity of a mixture of a compound having general formula (I) and another compound. The latter compound is selected from acetylcholinesterase inhibitors, gamma-aminobutyric acid-controlled chloride channel antagonist, sodium channel modulators or voltage-dependent sodium channel blockers, nicotine acetylcholine receptor agonist, allosteric acetylcholine receptor modulators, chloride channel activators, oxidative phosphorylation inhibitors, buprofezin, chitin biosynthesis inhibitors. The latter compound is selected from ecdysone agonist, octopaminergic agonist, electron transport inhibitor, fatty acid biosynthesis inhibitor, benclothiaz, methyl bromide, chloropicrin, sulfuryl fluoride, cryolite, pymetrozine, pyrifluquinazon, flonicamid, clofentezine, hexythiazox, etoxazole, chlorfenapyr, dinobuton, dinocap, Bacillus thuringiensis strain, cyromazine, amitraz, hydramethylnon, acequinocyl, fluacrypyrim, cyflumetofen, cyenopyrafen, bifenazate, flubendiamide, bromopropylate, chinomethionat, chlordimeform, chlorobenzilate, clothiazoben, cycloprene, dicofol, dicyclanil, fentrifanil, flubenzimine, flufenerim, flutenzin, gossyplure, japonilure, sulfluramid, tetrasul, triarathene, 4-(((6-bromo-pyridin-3-yl) methyl)(2-fluoroethyl)amino)furan-2-(5H)-one, 4-(((6-chloro-pyridin-3-yl)methyl)(2-fluoro-ethyl) mino)furan-2-(5H)-one, 4-(((6-chloro-5-fluoro-pyridin-3-yl) methyl)(methyl) amino)furan-2-(5H)-one, 1-(6-chloro pyridin-3-yl)ethyl (methyl)oxido-lambda 4 sulfanylidencyanamide, 1-(6-chloro-pyridin-3-yl)ethyl (methyl)oxido-lambda 4 sulfanylidencyanamide or its diastereomer having general formula (II, III), 6-(trifluormethyl-pyridin-3-yl)methyl (methyl)oxido-lambda 4-sulfanylidencyanamide or 1-(6-trifluoro-methylpyridin-3-yl)ethyl (methyl)oxido-lambda4-sulfanylidencyanamide or its diastereomer having general formula (IV,V). The compounds with general formulae (I-V). R1 : chlorine or cyano group. ORGANIC CHEMISTRY - Preferred Compounds: The acetylcholinesterase inhibitor is selected from carbamates or organophosphates.The carbamate is selected from alanycarb, aldicarb, aldoxycarb, allyxycarb, aminocarb, bendiocarb, benfuracarb, bufencarb, butacarb, butocarboxim, carbaryl, carbofuran, carbosulfan, cloethocarb, dimetilan, ethiofencarb, fenobucarb, fenothiocarb, formetanate, furathiocarb, isoprocarb, metam sodium, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, promecarb, propoxur, thiodicarb, thiofanox, trimethacarb or xylylcarb. The organophosphate is selected from a total of 89 compounds (Claimed), acephate, azamethiphos, azinphos (-methyl, -ethyl), bromfenvinfos (-methyl), butathiofos, cadusafos, carbophenothion, chlorethoxyfos, chlorfenvinphos, chlormephos, coumaphos, cyanofenphos, cyanophos, chlorfenvinphos, demeton-S-methyl, demeton-S-methyl sulfone, dialifos, diazinon, dichlofenthion, dichlorvos, dicrotophos, dimethoate, dimethylvinphos dioxabenzofos, disulfoton, ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fensulfothion, fenthion, flupyrazofos, fonofos, formothion, fosmethilan, fosthiazate, heptenophos, iodofenphos, iprobenfos, isazofos, isofenphos, isoxathion, malathion, mecarbam, methacrifos, methamidophos, methidathion, monocrotophos, naled or omethoate. The gamma-aminobutyric acid-controlled chloride channel antagonist is selected from camphechlor, chlordane, endosulfan, gamma-hexachlorocyclohexane, hexachlorocyclohexane, hepta chlorine, lindane, methoxychlor, acetoprole, ethiprole, fipronil, pyrafluprole, pyriprole or vaniliprole. The sodium channel modulator or voltage-dependent sodium channel blocker is selected from acrinathrin, allethrin, beta-cyfluthrin, bifenthrin, bioallethrin, bioallethrin-S-cyclopentyl isomer, bioethanomethrin, biopermethrin, bioresmethrin, chlovaporthrin, cis-cypermethrin, cis-resmethrin, cis-permethrin, clocythrin, cycloprothrin, cyfluthrin, cyhalothrin, cypermethrin (alpha-, beta-, theta-, zeta-), cyphenothrin, deltamethrin, empenthrin (1R)isomer, esfenvalerate, etofenprox, fenfluthrin, fenpropathrin, fenpyrithrin, fenvalerate, flubrocythrinate, flucythrinate, flufenprox, flumethrin, fluvalinate, fubfenprox, gamma cyhalothrin, imiprothrin, lambda cyhalothrin, metofluthrin, permethrin, phenothrin (1R-trans isomer), prallethrin, profluthrin, protrifenbute, pyresmethrin, resmethrin, silafluofen, fluvalinate, tefluthrin, terallethrin, tetramethrin (1R isomer), tralomethrin, transfluthrin, pyrethrin, dichloro-diphenyl-trichloroethane or methoxychlor The nicotine acetylcholine receptor agonist is selected from acetamiprid, clothianidin, dinotefuran, imidacloprid, imidaclothiz, nitenpyram, nithiazine, thiacloprid, thiamethoxam, nicotine, bensultap, cartap or thiosultap sodium. The allosteric acetylcholine receptor modulator is spinosyn selected from spinosad or spinetoram. The chloride channel activator is selected from abamectin, emamectin, emamectin benzoate, ivermectin, lepimectin, milbemectin, hydroprene, kinoprene, methoprene, epofenonane, triprene, fenoxycarb, pyriproxifen or diofenolan. The oxidative phosphorylation inhibitor is selected from diafenthiuron, azocyclotin, cyhexatin fenbutatin oxides, propargite or tetradifon. The chitin biosynthesis inhibitor is selected from bistrifluron, chlorfluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, penfluron, teflubenzuron or triflumuron. The ecdysone agonist is selected from chromafenozide, halofenozide, methoxyfenozide, tebufenozide, fufenozide or azadirachtin. The electron transport inhibitor is selected from fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad, tolfenpyrad, rotenone, indoxacarb or metaflumizone. The fatty acid biosynthesis inhibitor is selected from spirodiclofen, spiromesifen or spirotetramat. [Image] [Image] [Image] [Image] [Image].
机译:转基因植物生产潜力的利用涉及利用具有有效量的具有通式(I)的化合物和另一种化合物的混合物的植物。后一种化合物选自乙酰胆碱酯酶抑制剂,γ-氨基丁酸控制的氯离子通道拮抗剂,钠离子通道调节剂或电压依赖性钠离子通道阻滞剂,尼古丁乙酰胆碱受体激动剂,变构乙酰胆碱受体调节剂,氯离子通道激活剂,氧化磷酸化抑制剂,丁苯丙哌嗪,几丁质生物合成抑制剂。后一种化合物选自蜕皮激素激动剂,章鱼胺能激动剂,电子传递抑制剂,脂肪酸生物合成抑制剂,苯并吡咯,甲基溴,氯吡啶啉,硫酰氟,冰晶石,吡me嗪,吡氟喹唑酮,氟尼卡米,氯芬替星,己基氯苯并噻二酮,乙二唑,乙二唑,苏云金芽孢杆菌菌株,环丙嗪,阿米特拉斯,羟甲基农胺,乙酰喹啉基,氟嘧啶,氟美托芬,氰基吡喃,联苯肼酯,氟苯二酰胺,溴丙酸酯,甲氰菊酯,氯嘧啶,氯苯二甲腈,氟苯甲氰,氟苯甲酰,氟苯甲酰,氟苯二甲腈,氟苯丙胺,氟苯次萘,氟苯二甲腈,氟苯次萘,氟哌啶酮,氟苯二甲腈,氟苯次萘,氟苯二甲腈,氟苯次萘,氟苯次萘,氟苯次萘,氟苯次萘,氟苯次萘,氟苯次萘,氟苯次萘,氟苯次萘宁,磺胺嘧啶,四硫,三芳烃,4-(((6-溴-吡啶-3-基)甲基)(2-氟乙基)氨基)呋喃-2-(5H)-一,4-((((6-氯-吡啶-3-基)甲基)(2-氟乙基)氨基)呋喃-2-(5H)-一,4-((((6-氯-5-氟-吡啶-3-基)甲基)(甲基)氨基)呋喃-2-(5H)-一,1-(6-氯吡啶-3-基)乙基(甲基)氧化lambda 4磺酰胺基戊酰胺,具有通式(II,III)的1-(6-氯-吡啶-3-基)乙基(甲基)氧化-lambda 4磺酰二氮杂酰胺或其非对映异构体,6-(三氟甲基-吡啶-3-基)甲基(甲基)通式(IV,V)的氧化lambda 4-磺酰胺基戊酰胺或1-(6-三氟-甲基吡啶基-3-基)乙基(甲基)氧化lambda4-磺酰胺基戊酰胺或其非对映异构体。具有通式(I-V)的化合物。 R1:氯或氰基。有机化学-首选化合物:乙酰胆碱酯酶抑制剂选自氨基甲酸酯或有机磷酸盐。氨基甲酸酯,涕灭威,醛氧威,烯丙威,氨基碳水化合物,苯达威威,苯氟卡威,丁苯威,丁卡威,丁卡威,卡巴威,呋喃丹,二甲氨基苯甲酸,乙硫芬威,非诺威威,非诺威威,甲酸酯,呋喃硫威,异丙威,麦角钠,甲硫威,灭多威,灭多威,草酰胺,吡虫威,灭威威,丙草威,硫代双威,硫代恶威,三甲威或二甲苯甲威。有机磷酸盐选自89种化合物(权利要求书),乙酰甲酸盐,氮杂甲磷,谷硫磷(-甲基,-乙基),溴芬芬(-甲基),丁硫磷,cadusafos,碳苯甲硫磷,氯乙氧基磷,氯芬芬磷,氯甲磷,氰磷, ,三氯芬芬磷,十甲基-去甲基磺砜,二甲基十甲基-去甲基砜,dialogos,二嗪农,双氯芬硫磷,敌敌畏,双古磷,乐果,二甲基乙磷,二恶唑烷,二硫代芬,乙硫磷,乙草磷,乙草磷,氟虫草,氟虫草,氟虫草,氟虫草,苯硫磷,fonofos,formothion,fosmethilan,fosthiazate,heptenophos,iodofenphos,iprobenfos,isazofos,isofenphos,isooxathion,malathion,mecarbam,methacrifos,methamidophos,methidathion,久效磷,naled或omethothoate。 γ-氨基丁酸控制的氯离子通道拮抗剂选自樟二氯,氯丹,硫丹,γ-六氯环己烷,六氯环己烷,七氯,林丹,甲氧基氯,乙酰胺,乙腈,氟虫腈,吡虫啉,吡虫啉或香兰素。钠离子通道调节剂或电压依赖性钠离子通道阻滞剂选自:痤疮丙酸杆菌素,Allethrin,β-氯氟氰菊酯,联苯菊酯,生物菊酯,生物菊酯-S-环戊基异构体,生物乙菊酯,生物苄氯菊酯,生物菊酯,氯蒸发蛋白,顺式氯氰菊酯,顺式-间氯菊酯,顺式-氯菊酯,氯菊酯,环丙菊酯,氯氟氰菊酯,氟氯氰菊酯,氯氰菊酯(α-,β-,θ-,ζ-),氯苯菊酯,溴氰菊酯,Empenthrin(1R)异构体,艾芬戊酸酯,依托非布洛芬,芬氟菊酯,苯丙菊酯,苯并丙氨酸酯氟氰菊酯,氟苯丙草胺,氟甲氰菊酯,氟伐林酸酯,氟苯甲草胺,γ氟氯氰菊酯,丙咪嗪,lambda氟氯氰菊酯,异氟菊酯,氯菊酯,苯乙炔菊酯(1R-反式异构体),普兰菊酯,甲氨蝶呤,氟虫菊酯,四氢菊酯,四氢菊酯,四氢菊酯,四氢菊酯,四氢菊酯,四氢菊酯,四氢菊酯,四氢菊酯,四氢菊酯,四氢菊酯,四氢菊酯,四氟菊酯,四氟菊酯,四氟菊酯,四氟菊酯,四氟菊酯,四氟菊酯,四氟菊酯,四氟菊酯,四氟菊酯,四氟菊酯,四氟菊酯,四氢菊酯,四氟菊酯,四氟菊酯,三氟甲磺酸菊酯,四氟菊酯,四氟菊酯,三氟甲磺酸菊酯,氟苯菊酯1R异构体),溴氰菊酯,跨氟菊酯,除虫菊酯,二氯二苯基三氯乙烷或甲氧基氯尼古丁乙酰胆碱受体nist选自扑热息痛,可尼丁,二甲呋喃,吡虫啉,吡虫啉,尼替吡兰,硝噻嗪,噻虫啉,噻虫嗪,尼古丁,苄索普,卡帕普或噻菌灵钠。变构乙酰胆碱受体调节剂是选自多杀菌素或多杀菌素的多杀菌素。氯离子通道激活剂选自阿维菌素,阿曼菌素,苯甲酰胺阿玛菌素,伊维菌素,纤连蛋白,milbemectin,氢化异戊二烯,基诺丁烯,甲基异戊二烯,环氧丁酮,三丁烯,苯氧威,吡虫啉或地非诺兰。氧化磷酸化抑制剂选自二苯噻隆,偶氮环丁,环己基芬丁丁氧化物,炔丙基酯或丁苯二酮。几丁质生物合成抑制剂选自双曲氟龙,氯氟嘧磺隆,双氟苯磺隆,氟嘧磺隆,氟环草隆,氟苯氟隆,六氟磺隆,氟苯磺隆,诺富隆,诺氟龙,戊氟隆,替氟苯隆或三氟磺隆。蜕皮激素激动剂选自苯甲酰肼,氟苯甲酰肼,甲氧苯甲酰肼,丁苯甲酰肼,氟苯乙酰肼或印za素。该电子传输抑制剂选自法尼扎喹,芬吡肟酯,嘧啶酮,哒嗪苯,替布芬吡拉德,托芬吡拉德,鱼藤酮,茚虫威或间氟米松。脂肪酸生物合成抑制剂选自螺二氯芬,螺西美芬或螺四氮。 [图像] [图像] [图像] [图像] [图像]。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号